This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Paul M. Fischer, MD; Katherine H. Guinan; James J. Burke II, MD; Warren B. Karp, PhD, DMD; John W. Richards, Jr, MD

Arch Intern Med. 1990;150(12):2567-2572.

Abstract
• The National Cholesterol Education Program (NCEP) has endorsed physician case finding as the primary method to detect individuals with elevated cholesterol levels. Despite this recommendation, promotional and for-profit public screening programs have flourished. We surveyed participants of a mall-based cholesterol screening program 1 year after their screening. Sixty-four percent of those screened had not previously known their cholesterol levels. Those who were newly screened were less likely to benefit from this testing than the general public, since they were older (mean age, 55.3 years), more likely to be female (67.4%), and nonsmokers (88%). Screenees had excellent recall of their cholesterol level (mean absolute reporting error, 0.24 mmol/L [9 mg/dL]) and a good understanding of cholesterol as a coronary heart disease risk. Those with elevated cholesterol levels reported high distress from screening but no reduction in overall psychosocial well-being and an actual decrease in absenteeism. Only 53.7% of all who were advised to seek follow-up because of an elevated screening value had done so within the year following the screening program. However, of those with values greater than 6.2 mmol/L (240 mg/dL), 68% had sought follow-up. Many of those who participate in public screening programs have been previously tested, fall into low-benefit groups, or fail to comply with recommended follow-up. We therefore conclude that cholesterol screening programs of the type now commonly offered are unlikely to contribute greatly to the national efforts to further reduce coronary heart disease.

(Arch Intern Med. 1990;150:2567-2572)

Author Affiliations
From the Departments of Family Medicine (Drs Fischer, Burke, and Richards and Ms Guinan) and Pediatrics (Dr Karp), Medical College of Georgia, Augusta.

Footnotes
Accepted for publication July 30,1990.

Reprint requests to Department of Family Medicine, Medical College of Georgia, Augusta, GA 30912 (Dr Fischer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quality of life in a family based genetic cascade screening programme for familial hypercholesterolaemia: a longitudinal study among participants
van Maarle et al.
J. Med. Genet. 2003;40:e3-3.
FULL TEXT  

Evaluating Cholesterol Screening: The Importance of Controlling for Regression to the Mean
Forrow et al.
Arch Intern Med 1995;155:2177-2184.
ABSTRACT  

Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project
Havas et al.
JAMA 1991;266:375-381.
ABSTRACT